This is the week that the broad outlines of President Trump’s reelection strategy are coming into focus. Trump will continue pushing forward with his reactionary xenophobic nationalist agenda on immigration, while executing a massive but largely phony pivot back to the pro-worker economic populism he immediately abandoned upon taking office.
But Democrats and progressives believe they may have found a way to unmask that sham populist pivot. And their developing counterargument involves not one, but two, of the issues on which Trump will build his case for reelection: prescription drugs and trade.
This counterargument surfaced almost by surprise in a series of focus groups recently conducted in the industrial Midwest by veteran Democratic pollster Stan Greenberg, for the trade watchdog group Public Citizen. Greenberg outlined his findings in a memo that was shared with this blog.
